BDBM275021 N8-(2-(6-methoxy-1H-benzo[d]imidazol-2- yl)ethyl)-N2-(2,2,2-trifluoroethyl)-5-(3- (trifluoromethyl)phenyl)-3,4- dihydroisoquinoline-2,8(1H)-dicarboxamide::US9877957, Example 59

SMILES COc1ccc2nc(CCNC(=O)c3ccc(-c4cccc(c4)C(F)(F)F)c4CCN(Cc34)C(=O)NCC(F)(F)F)[nH]c2c1

InChI Key InChIKey=KNWWIHBVVRZKLH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 275021   

TargetDiacylglycerol O-acyltransferase 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM275021(N8-(2-(6-methoxy-1H-benzo[d]imidazol-2- yl)ethyl)-...)
Affinity DataIC50: 82.9nMpH: 7.0 T: 2°CAssay Description:DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2018
Entry Details
Go to US Patent